In mesothelioma, due to the NF2 or LATS2 loss, Hippo signaling becomes dysregulated [97, 98, 99], although the observation of frequent subclonal NF2 mutations detected in clinical samples suggests that it may occur later in mesothelioma development [19, 100]. This evidence concerns the gene NF2 and mesothelioma.